Present status of chymopapain and chemonucleolysis

E. J. Nordby, Mark Brown

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

An analysis of recent events and newly published data on Chymopapain and the technique of Chemonucleolysis including an objective analysis of clinical and basic research as well as the circumstances leading to the Food & Drug Administration curtailment of the use of Chymopapain in the United States, indicate that the drug should be reapproved for investigational use.

Original languageEnglish
Pages (from-to)79-83
Number of pages5
JournalClinical Orthopaedics and Related Research
VolumeNo. 129
StatePublished - Dec 1 1977

Fingerprint

Intervertebral Disc Chemolysis
Chymopapain
Pharmaceutical Preparations
Food
Research

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Present status of chymopapain and chemonucleolysis. / Nordby, E. J.; Brown, Mark.

In: Clinical Orthopaedics and Related Research, Vol. No. 129, 01.12.1977, p. 79-83.

Research output: Contribution to journalArticle

@article{871fa036ca8a4d8cb2b916f7b8f9f01d,
title = "Present status of chymopapain and chemonucleolysis",
abstract = "An analysis of recent events and newly published data on Chymopapain and the technique of Chemonucleolysis including an objective analysis of clinical and basic research as well as the circumstances leading to the Food & Drug Administration curtailment of the use of Chymopapain in the United States, indicate that the drug should be reapproved for investigational use.",
author = "Nordby, {E. J.} and Mark Brown",
year = "1977",
month = "12",
day = "1",
language = "English",
volume = "No. 129",
pages = "79--83",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",

}

TY - JOUR

T1 - Present status of chymopapain and chemonucleolysis

AU - Nordby, E. J.

AU - Brown, Mark

PY - 1977/12/1

Y1 - 1977/12/1

N2 - An analysis of recent events and newly published data on Chymopapain and the technique of Chemonucleolysis including an objective analysis of clinical and basic research as well as the circumstances leading to the Food & Drug Administration curtailment of the use of Chymopapain in the United States, indicate that the drug should be reapproved for investigational use.

AB - An analysis of recent events and newly published data on Chymopapain and the technique of Chemonucleolysis including an objective analysis of clinical and basic research as well as the circumstances leading to the Food & Drug Administration curtailment of the use of Chymopapain in the United States, indicate that the drug should be reapproved for investigational use.

UR - http://www.scopus.com/inward/record.url?scp=0017612148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017612148&partnerID=8YFLogxK

M3 - Article

C2 - 608299

AN - SCOPUS:0017612148

VL - No. 129

SP - 79

EP - 83

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

ER -